Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Seacross Pharma is a specialty pharmaceutical company focused on the development, registration, and commercialization of high-quality generic and value-added medicines. Headquartered in the United Kingdom with significant operations in China, the company specializes in therapeutic areas such as oncology, critical care, and cardiovascular health. Seacross manages a diverse portfolio of injectable and oral products, leveraging its expertise in global regulatory affairs and supply chain management to bring cost-effective treatments to international markets. The company's business model encompasses both internal product development and strategic partnerships for distribution and licensing. By bridging the gap between Asian manufacturing capabilities and Western regulatory standards, Seacross ensures a reliable supply of essential medicines to healthcare providers worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Seacross Pharma.